Anika Therapeutics, Inc. (ANIK)

NMS – Real Time Price. Currency in USD

14.68

+0.14 (0.96%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

113M

120M

121M

156M

Cost of goods sold

-49M

-44M

-38M

-63M

Gross Profit

64M

76M

83M

94M

Operating expenses (excl. COGS)

-75M

-81M

-82M

-113M

Operating Income

-11M

-5M

844K

-19M

Non-operating income, total

654K

Pretax income

-9M

-3M

-19M

Equity in earnings

Taxes

-672K

-6M

-7M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-10M

-9M

-3M

-15M

Anika Therapeutics, Inc. (ANIK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Anika Therapeutics, Inc. (ANIK)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Anika Therapeutics, Inc. (ANIK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Anika Therapeutics, Inc. (ANIK)

Income Statement (Annual)

Income Statement (Annual)